Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic.
A Calgary clinic has received provisional accreditation to provide a novel way of administering the psychedelic drug ketamine ...
Ketamine, a non-competitive N-methyl-D-aspartate receptor antagonist, has emerged as an effective therapeutic agent for the management of treatment-resistant depression. Repeated treatments with ...
1d
News Medical on MSNExploring ketamine's potential in the fight against treatment-resistant depressionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing to treatment-resistant depression (TRD).
Tech mogul Bryan Johnson, known for his radical anti-aging methods, admitted to injecting himself with Ketamine, a horse ...
IntroductionMajor depressive disorder (MDD) is a leading cause of disability worldwide, with a significant proportion of patients (10-20%) progressing ...
The drug is approved for use by doctors and veterinarians as an anesthetic—but is also capable of producing hallucinogenic ...
Ketamine has received a Hollywood makeover. It used to be known as a rave drug (street name special K) and cat anesthetic. However, in recent years, some doctors have prescribed ketamine to treat ...
New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.
B-2D, a brain receptor targeted by ketamine. Using cryo-EM, they visualize how ketamine binds to the receptor, controlling its ion channel activity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results